Arkolith/Insider Trading/GMTX/Form 4

Tananbaum James B.

Director, 10% OwnerGemini Therapeutics, Inc. /DE (GMTX) · full profile →Form 4 · filed Oct 6, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 4, 2021Grant(A)17K—$017K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-039457) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML